(19)
(11) EP 2 611 465 A2

(12)

(88) Date of publication A3:
31.05.2012

(43) Date of publication:
10.07.2013 Bulletin 2013/28

(21) Application number: 11822530.9

(22) Date of filing: 31.08.2011
(51) International Patent Classification (IPC): 
A61K 39/42(2006.01)
C07K 16/00(2006.01)
(86) International application number:
PCT/US2011/049880
(87) International publication number:
WO 2012/030904 (08.03.2012 Gazette 2012/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.08.2010 US 378604 P
27.09.2010 US 386940 P
19.04.2011 US 201161476978 P
05.08.2011 US 201161515548 P

(71) Applicants:
  • Theraclone Sciences, Inc.
    Seattle, WA 98104 (US)
  • The Scripps Research Institute
    La Jolla, CA 92037 (US)
  • International Aids Vaccine Initiative
    New York, NY 10004 (US)

(72) Inventors:
  • CHAN-HUI, Po-ying
    Bellevue, WA 98005 (US)
  • DOORES, Katherine
    San Diego, CA 92109 (US)
  • HUBER, Michael
    CH-8008 Zurich (CH)
  • KAMINSKY, Stephen
    Bronx, NY 10471 (US)
  • FREY, Steven
    Redmond, WA 98053 (US)
  • OLSEN, Ole
    Everett, WA 98208 (US)
  • MITCHAM, Jennifer
    Redmond, WA 98053 (US)
  • MOYLE, Matthew
    Redmond, WA 98052 (US)
  • PHOGAT, Sanjay K.
    Frederick, MD 21701 (US)
  • BURTON, Dennis R.
    La Jolla, CA 92037 (US)
  • WALKER, Laura Marjorie
    San Diego, CA 92122 (US)
  • POIGNARD, Pascal Raymond Georges
    San Diego, CA 92109 (US)
  • KOFF, Wayne
    Stony Brook, NY 11790 (US)
  • SIMEK-LEMOS, Melissa Danielle, de Jean de St. Marcel
    Brooklyn, NY 11231 (US)

(74) Representative: Schüssler, Andrea et al
Kanzlei Huber & Schüssler Truderinger Strasse 246
81825 München
81825 München (DE)

   


(54) HUMAN IMMUNODEFICIENCY VIRUS (HIV)-NEUTRALIZING ANTIBODIES